ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
Zatímco jiné nástroje vám berou čas, my vám pomůžeme za pár minut kvalifikovat firmy, které k vám opravdu sedí. Váš pipeline tak zůstane zdravý, tým produktivní a obchody se uzavírají rychleji.